These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
770 related articles for article (PubMed ID: 30694095)
1. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications. Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095 [TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation. Burnouf T; Agrahari V; Agrahari V Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783 [TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles for drug delivery. Vader P; Mol EA; Pasterkamp G; Schiffelers RM Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656 [TBL] [Abstract][Full Text] [Related]
4. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807 [TBL] [Abstract][Full Text] [Related]
5. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery. Ingato D; Lee JU; Sim SJ; Kwon YJ J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180 [TBL] [Abstract][Full Text] [Related]
6. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. Fais S; O'Driscoll L; Borras FE; Buzas E; Camussi G; Cappello F; Carvalho J; Cordeiro da Silva A; Del Portillo H; El Andaloussi S; Ficko Trček T; Furlan R; Hendrix A; Gursel I; Kralj-Iglic V; Kaeffer B; Kosanovic M; Lekka ME; Lipps G; Logozzi M; Marcilla A; Sammar M; Llorente A; Nazarenko I; Oliveira C; Pocsfalvi G; Rajendran L; Raposo G; Rohde E; Siljander P; van Niel G; Vasconcelos MH; Yáñez-Mó M; Yliperttula ML; Zarovni N; Zavec AB; Giebel B ACS Nano; 2016 Apr; 10(4):3886-99. PubMed ID: 26978483 [TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle-based drug delivery systems for cancer treatment. Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377 [TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495 [TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines. Kotmakçı M; Bozok Çetintaş V J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135 [TBL] [Abstract][Full Text] [Related]
10. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System. Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615 [TBL] [Abstract][Full Text] [Related]
11. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading. Sutaria DS; Badawi M; Phelps MA; Schmittgen TD Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083 [TBL] [Abstract][Full Text] [Related]
12. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity. Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896 [TBL] [Abstract][Full Text] [Related]
13. Emerging Significance and Therapeutic Potential of Extracellular vesicles. Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688 [TBL] [Abstract][Full Text] [Related]
15. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Meng W; He C; Hao Y; Wang L; Li L; Zhu G Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719 [TBL] [Abstract][Full Text] [Related]
16. Targeting Inflammatory Vasculature by Extracellular Vesicles. Wang S; Dong X; Gao J; Wang Z AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558 [TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics. Liu C; Gao H; Lv P; Liu J; Liu G Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786 [TBL] [Abstract][Full Text] [Related]
18. Chromatography and its hyphenation to mass spectrometry for extracellular vesicle analysis. Pocsfalvi G; Stanly C; Fiume I; Vékey K J Chromatogr A; 2016 Mar; 1439():26-41. PubMed ID: 26830636 [TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles in the Development of Cancer Therapeutics. Sun H; Burrola S; Wu J; Ding WQ Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103 [TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles as Biological Shuttles for Targeted Therapies. Raimondo S; Giavaresi G; Lorico A; Alessandro R Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]